Steven Cohen Puma Biotechnology, Inc. Transaction History

Point72 Asset Management, L.P.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$2.21 - $4.82 $24,310 - $53,020	11,000 New	11,000 $33,000
Q1 2020 May 15, 2020	SELL	$6.28 - $14.57 $2.59 Million - $6 Million	-411,978 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$6.5 - $10.73 $612,579 - $1.01 Million	-94,243 Reduced 18.62%	411,978 $3.61 Million
Q3 2019 Nov 15, 2019	BUY	$8.75 - $12.85 $2.34 Million - $3.43 Million	267,048 Added 111.65%	506,221 $5.45 Million
Q2 2019 Aug 14, 2019	BUY	$12.3 - $35.76 $2.92 Million - $8.5 Million	237,773 Added 16983.79%	239,173 $3.04 Million
Q1 2019 May 15, 2019	SELL	$20.77 - $42.37 $3.15 Million - $6.43 Million	-151,758 Reduced 99.09%	1,400 $54,000
Q4 2018 Feb 14, 2019	SELL	$20.07 - $46.7 $12.3 Million - $28.6 Million	-611,432 Reduced 79.97%	153,158 $3.12 Million
Q3 2018 Nov 14, 2018	SELL	$41.2 - $59.85 $6.39 Million - $9.29 Million	-155,185 Reduced 16.87%	764,590 $35.1 Million
Q2 2018 Aug 14, 2018	SELL	$48.3 - $68.25 $17.5 Million - $24.7 Million	-361,342 Reduced 28.21%	919,775 $54.4 Million
Q1 2018 May 15, 2018	BUY	$59.7 - $99.25 $60.9 Million - $101 Million	1,020,265 Added 391.13%	1,281,117 $87.2 Million
Q4 2017 Feb 14, 2018	SELL	$93.85 - $132.45 $20.8 Million - $29.3 Million	-221,348 Reduced 45.9%	260,852 $25.8 Million
Q3 2017 Nov 14, 2017	BUY	$72.0 - $119.75 $34.7 Million - $57.7 Million	482,200	482,200 $57.7 Million

110

28.3M

27.9K

3.4K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $155M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.